• AmWINS published its inaugural 2026 State of the Market report covering employee benefits beyond stop-loss across a USD 11.7 billion book.
• Report flags tightening conditions, citing a 6% to 9% median medical plan cost trend increase in 2026 renewals, the highest in over a decade.
• Carriers are applying 10% to 12% medical cost trends in formula renewals, with buffers for volatility, high-cost claims.
• Prescription drugs drive the largest estimated plan increases at 11%; specialty drugs are under 2% of prescriptions but near 50% of drug spend.
• Stop-loss market growth pegged at 15% CAGR, projected to reach USD 113.5 billion by 2034; weaker self-funded groups face caps or non-renewals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AmWINS Group Inc. published the original content used to generate this news brief on May 26, 2026, and is solely responsible for the information contained therein.